Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3801–3850 of 18625
In connection with the Strategic Pivot, Fred Schwarzer resigned as Chief Executive Officer, President and a member of the board of directors (the “Board”) of the Company, effective as of September 30, 2024 (the “Effective Date”).
William J. Skrobacz will step down as Vice President and Chief Financial Officer of the Company effective December 31, 2024, as he intends to retire from the Company in 2025.
The Company also announced that, effective January 1, 2025, Timothy K. Fitzgerald will succeed Mr. Skrobacz as Vice President and Chief Financial Officer of the Company.
On September 27, 2024, Joseph Matozzo and Michael A. Coates stepped down as the chief executive officer and chief financial officer, respectively
On September 27, 2024, Joseph Matozzo and Michael A. Coates stepped down as the chief executive officer and chief financial officer, respectively
on August 1, 2024, Michael Guthrie, the Company’s Chief Financial Officer, notified Roblox Corporation (the “Company”) of his intent to resign as Chief Financial Officer to pursue personal interests.
the Board has appointed Luis Fernandez-Moreno as the interim President and Chief Executive Officer of the Company
He succeeds John C. Fortson, who departed as President and Chief Executive Officer and has resigned as a member of the Board, effective as of October 2, 2024.
On October 1, 2024, the Company announced the appointment of Mark Goldstone, a member of the Company’s board of directors, to serve as the Company’s Interim President and Interim Chief Executive Officer, effective October 18, 2024.
Mr. Long also resigned from his position as a member of the Board and as President and Chief Executive Officer.
the Board appointed Micah Clint Green, as President and Chief Executive Officer of the Company effective October 3, 2024.
appointed James B. Frakes to serve as the Company’s permanent Chief Executive Officer
On September 27, 2024, the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”) appointed Katharyn Field, a member of the Board, to also serve as a Vice President (principal executive officer) of the Company, effective immediately.
On October 1, 2024, Mitek Systems, Inc. (the “Company”) announced that Edward H. West was appointed as the Company’s Chief Executive Officer, effective immediately.
On October 2, 2024, Murphy Oil Corporation (the “Company”) announced that the Board of Directors (the “Board”) has unanimously appointed Eric M. Hambly, currently the Company's President and Chief Operating Officer, as the President and Chief Executive Officer, effective as of January 1, 2025, and has also elected Mr. Hambly to the Board, effective as of January 1, 2025.
Mr. Hambly will be succeeding Roger W. Jenkins, who will be retiring as Chief Executive Officer of the Company and as a member of the Board, effective as of December 31, 2024, and thereafter is expected to serve as a non-executive employee.
Effective at the completion of the Merger, Tanay Tandon became President and Chief Executive Officer, Daniel Brian became Chief Financial Officer, Treasurer and Secretary and Deepika Bodapati became Chief Operating Officer of the Company.
Effective at the completion of the Merger, Tanay Tandon became President and Chief Executive Officer, Daniel Brian became Chief Financial Officer, Treasurer and Secretary and Deepika Bodapati became Chief Operating Officer of the Company.
Conor M. Fennerty, Executive Vice President, Chief Financial Officer and Treasurer of SITE Centers, and Christina M. Yarian, Senior Vice President and Chief Accounting Officer of SITE Centers, resigned from the Company, effective as of September 30, 2024.
On the Spin Off Date, the Board appointed Gerald R. Morgan as Executive Vice President, Chief Financial Officer and Treasurer of SITE Centers and Jeffrey A. Scott as Senior Vice President and Chief Accounting Officer of SITE Centers, each effective as of the Spin Off Date.
On September 30, 2024, the Board appointed Georgia Erbez as the Company’s Chief Financial Officer, replacing Sriram Ryali in such role, effective September 30, 2024.
On September 30, 2024, the Board appointed Georgia Erbez as the Company’s Chief Financial Officer, replacing Sriram Ryali in such role, effective September 30, 2024.
On September 30, 2024, the Board of Directors (the “Board”) of the Company notified Brent Bellm that his employment as the Company’s Chief Executive Officer was terminated.
On September 30, 2024, the Board appointed Travis Hess, previously President of the Company, to succeed Mr. Bellm as the Company’s Chief Executive Officer, effective October 1, 2024.
As previously announced, Charles R. Carter resigned from his position as Chief Financial Officer, effective on September 30, 2024.
On September 30, 2024, the Board appointed Andrew Albert “Al” Kucharchuk as Chief Financial Officer of the Company, effective October 1, 2024.
On September 26, 2024, John D. Murphy, Jr resigned as Director and CEO of the Company.
On September 26, 2024, Evan Bloomberg was nominated as Director of the Company and appointed CEO of the Company.
replacing Lexaria’s former CFO, Nelson Cabatuan who resigned effective July 15, 2024
Richard Christopher, the Company’s Chief Executive Officer who assumed the responsibilities as the Company’s principal financial officer on an interim basis, relinquished those responsibilities to Mr. Shankman.
Effective October 1, 2024, Michael Shankman, age 64, has been appointed to the position of Chief Financial Officer of Lexaria Bioscience Corp.
the Board has appointed J.K. Symancyk to succeed Ms. Drosos as Chief Executive Officer and join the Board as of the Transition Date.
Virginia “Gina” C. Drosos is planning to retire as Chief Executive Officer and as a member of the Board of Directors of the Company (the “Board”), effective November 4, 2024
On October 1, 2024, the Company announced that Jeffrey Knudson will step down from his role as Chief Financial Officer of the Company, effective November 8, 2024, to pursue an opportunity with a private company outside of the healthcare staffing industry.
On October 1, 2024, the Company also announced that Thomas A. George, Senior Vice President, Finance and Chief Financial Officer, will be leaving the Company as part of his planned retirement.
On October 1, 2024, Genesco Inc. (the “Company”) announced the appointment of Cassandra “Sandra” Harris as Senior Vice President, Finance and Chief Financial Officer of the Company, effective October 7, 2024
the Board of Directors (the “Board”) of the Company named Preston D. Wigner, Senior Vice President, as Chairman of the Board (“Chairman”), President and Chief Executive Officer of the Company (the “Appointment”), effective October 1, 2024
George C. Freeman, III, will retire as Chairman, President and Chief Executive Officer and as a member of the Board on the Effective Date
notified the Boards of Directors of the Company, TBI and the Bank of his decision to retire from the Boards of Directors of the Company, TBI and the Bank, and as President of the Company, President and Chief Executive Officer of TBI, and President and Chief Executive Officer of the Bank in 2025
appoint Mr. A. Haag Sherman to serve as President of the Company, Chief Executive Officer of TBI and Chief Executive Officer of the Bank, effective upon the termination of employment of Mr. Howard
The Company's Board of Directors formally appointed Mr. Broos as the Company's Interim Chief Financial Officer, effective immediately.
Wade King's departure from the role of Chief Financial Officer.
Also, on September 30, 2024, the Board appointed Richard A. Wurster to succeed Mr. Bettinger as CEO, effective as of January 1, 2025 (the “Transition Date”).
Kelly Steckelberg will continue to serve as the Company’s Chief Financial Officer until the Effective Date, upon which time she will transition to an advisory role.
the Company announced the appointment of Michelle Chang as the Company’s Chief Financial Officer, effective on or about October 7, 2024
the officers of Old BlackRock immediately prior to the Merger Effective Time became the officers of New BlackRock.
the officers of Old BlackRock immediately prior to the Merger Effective Time became the officers of New BlackRock.
Laurence Fink Chief Executive Officer
Martin Small Chief Financial Officer and Senior Managing Director
On October 1, 2024 Opendoor Technologies Inc. (the “Company”) announced the appointment of Selim F. Freiha as the Chief Financial Officer of the Company effective as of November 4, 2024
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.